These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39259658)
1. Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma. Bao H; Jiang Y; Wang N; Su H; Han X Cancer Control; 2024; 31():10732748241284821. PubMed ID: 39259658 [TBL] [Abstract][Full Text] [Related]
2. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma. Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618 [TBL] [Abstract][Full Text] [Related]
3. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601 [TBL] [Abstract][Full Text] [Related]
4. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma. Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668 [TBL] [Abstract][Full Text] [Related]
5. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma. Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma. Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma. Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585 [TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis. Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068 [TBL] [Abstract][Full Text] [Related]
9. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients. Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106 [TBL] [Abstract][Full Text] [Related]
10. Identification of long non-coding RNA Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565 [TBL] [Abstract][Full Text] [Related]
11. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864 [TBL] [Abstract][Full Text] [Related]
12. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Chao Y; Zhou D Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma. Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272 [TBL] [Abstract][Full Text] [Related]
14. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: A case-control study. Wang BG; Xu Q; Lv Z; Fang XX; Ding HX; Wen J; Yuan Y World J Gastroenterol; 2018 Jun; 24(23):2482-2490. PubMed ID: 29930469 [TBL] [Abstract][Full Text] [Related]
15. Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma. Han Y; Jiang W; Wang Y; Zhao M; Li Y; Ren L BMC Cancer; 2022 Apr; 22(1):431. PubMed ID: 35443674 [TBL] [Abstract][Full Text] [Related]
16. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection. Song X; Wu A; Ding Z; Liang S; Zhang C Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467 [TBL] [Abstract][Full Text] [Related]
17. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers. Kim SS; Baek GO; Son JA; Ahn HR; Yoon MK; Cho HJ; Yoon JH; Nam SW; Cheong JY; Eun JW Mol Oncol; 2021 Oct; 15(10):2715-2731. PubMed ID: 34185961 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of long non-coding RNA Liao X; Chen J; Luo D; Luo B; Huang W; Xie W Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103 [No Abstract] [Full Text] [Related]
19. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]